aid: pharmazz
name: Pharmazz
description: >-
  Pharmazz, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in
  Willowbrook, Illinois, founded and led by pharmacologist Dr. Anil Gulati. The company discovers,
  develops and commercializes first-in-class therapeutics for critical care and neurovascular
  medicine, built around two lead small-molecule candidates: centhaquine (Lyfaquin), a resuscitative
  agent for hypovolemic shock that holds marketing authorization from the Drugs Controller General
  of India and is licensed to Dr. Reddy's Laboratories for the Indian market, and sovateltide
  (Tycamzzi), an endothelin-B receptor agonist for cerebral ischemic stroke. Additional pipeline
  programs target septic shock, acute kidney injury, cardiac arrest, acute spinal cord injury,
  hypoxic-ischemic encephalopathy and Alzheimer's disease. Pharmazz is a drug-development company,
  not a software vendor; its public web presence is a corporate and investor brochure site and it
  operates no developer program, public API, SDK or machine-readable interface.
url: https://raw.githubusercontent.com/api-evangelist/pharmazz/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Healthcare
- Clinical Trials
- Critical Care
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/pharmazz-domain-security.yml
- type: Website
  url: https://www.pharmazz.com/
- type: About
  url: https://www.pharmazz.com/about-us.php
- type: Contact
  url: https://www.pharmazz.com/contact-us.php
- type: Careers
  url: https://www.pharmazz.com/career.php
- type: Press
  url: https://www.pharmazz.com/press-releases.php
- type: Investors
  url: https://www.pharmazz.com/investors.php
- type: Publications
  url: https://www.pharmazz.com/publications.php
- type: LinkedIn
  url: https://www.linkedin.com/company/pharmazz
- type: Sitemap
  url: https://www.pharmazz.com/sitemap.xml
- type: LLMsTxt
  url: llms/pharmazz-llms.txt

x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Pharmazz is a clinical-stage drug developer whose entire public presence is a 33-page
    static PHP brochure site listing its centhaquine and sovateltide trial programs; there is
    no /developers, /docs or /api path, no GitHub organization, and every contract-discovery
    probe against www.pharmazz.com returned the site's standard 404 page.
  evidence:
  - url: https://www.pharmazz.com/developers
    status: 404
  - url: https://www.pharmazz.com/openapi.json
    status: 404
  - url: https://www.pharmazz.com/.well-known/agent-card.json
    status: 404
  - url: https://www.pharmazz.com/sitemap.xml
    status: 200
  checked: '2026-08-26'